Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD

European Respiratory Journal

Volumn 13, Issue 4, 1999, Pages 850-854

  Maltais, F ^a   Sullivan, M J ^b   LeBlanc, P ^a   Duscha, B D ^b   Schachat, F H ^b   Simard, C ^c   Blank, J M ^b   Jobin, J ^a  

^a LAVAL UNIVERSITY   (Canada)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

Exercise; Lung disease; Skeletal muscle

Indexed keywords

MYOSIN HEAVY CHAIN;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXERCISE TEST; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; MUSCLE BIOPSY; MUSCLE FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASTUS LATERALIS MUSCLE;

AGED; BIOPSY; CASE-CONTROL STUDIES; EXERCISE TEST; EXERCISE TOLERANCE; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MUSCLE, SKELETAL; MYOSIN HEAVY CHAINS; RESPIRATORY FUNCTION TESTS;

EID: 0032938065     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.13d26.x     Document Type: Article

References (32)

1. Jones NL, Killian KJ. Limitation of exercise in chronic airway obstruction. In: Chemiack NS, ed. Chronic Obstructive Pulmonary Disease. Philadelphia, W.B. Saunders; 1991; pp. 196-206.
2. Williams TJ, Patterson GA, Mcclean PA, Zamel N, Maurer JR. Maximal exercise testing in single and double lung transplant recipients. Am Rev Respir Dis 1992; 145: 101-105.
3. Jakobsson P, Jorfeldt L, Brundin A. Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur Respir J 1990; 3: 192-196.
4. Hildebrand IL, Sylvén C, Esbjomsson M, Hellstrom K, Jansson E. Does hypoxaemia induce transformations of fiber types? Acta Physiol Scand 1991; 141: 435-439.
5. Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995; 152: 2021-2031.
6. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153: 976-980.
7. Maltais F, Simard AA, Simard C, Jobin J, Desgagnés P, Leblanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996; 153: 288-293.
8. Whittom F, Jobin J, Simard PM, et al. Histochemical and morphological characteristics of the vastus lateralis muscle in COPD patients. Comparison with normal subjects and effects of exercise training. Med Sci Sports Exerc 1998; 30: 1467-1474.
9. Satta A, Migliori GB, Spanevello A, et al. Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. Eur Respir J 1997; 10: 2853-2860.
10. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-244.
11. Knudson RJ, Slatin RC, Lebowitz MD, Burrows B. The maximal expiratory flow-volume curve. Normal standards, variability and effects of age. Am Rev Respir Dis 1976; 113: 587-600.
12. Goldman HI, Becklake MR. Respiratory function tests: normal values at median altitudes and the prediction of normal results. Am Rev Tuberc 1959; 79: 454-467.
13. Cotes JE, Hall AM. The transfer factors for the lung; normal values in adults. In: Arcangeli P, ed. Normal Values for Respiratory Function in Man. Torino, Panminerva Medica, 1970; pp. 327-343.
14. Bergström J. Muscle electrolytes in man. Determination by neutron activation analysis on needle biopsy specimens. A study on normal subjects, kidney patients and patients with chronic diarrhoea. Scand J Clin Lab Invest 1962; 14: 1-110.
15. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990; 81: 518-527.
16. Borg G. Psychophysical bases of perceived exertion. Med Sd Sports Exer 1982; 14: 377-381.
17. Talmadge RJ, Roy RR. Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. J Appl Physiol 1993; 75: 2337-2340.
18. Ennion S, Pereira JS, Sargeant AJ, Young A, Goldspink G. Characterization of human skeletal muscle fibres according to the myosin heavy chain they express. J Muscle Res Cell Motility 1995; 16: 35-43.
19. Smerdu V, Karsch-Mizrachi I, Campione M, Leinwand L, Schiaffino S. Type 2X myosin heavy chain transcripts are expressed in type 2B fibres of human skeletal muscle. Am J Physiol 1994; 267: C1723-C1728.
20. Clark TJH, Freedman S, Campbell EJM, Winn R. The ventilatory capacity of patients with chronic airway obstruction. Clin Sci 1969; 36: 307-316.
21. Adams GR, Hather BM, Baldwin KM, Dudley GA. Skeletal muscle myosin heavy chain composition and resistance training. J Appl Physiol 1993; 74: 911-915.
22. Staron RS, Johnson P. Myosin polymorphism and differential expression in adult human skeletal muscle. Comp Biochem Physiol 1993; 106: 463-475.
23. Sullivan VK, Powers SK, Criswell DS, Turmer N, Larochelle JS, Lowenthal D. Myosin heavy chain composition in young and old rat skeletal muscle: effects of endurance training. J Appl Physiol 1995; 78: 2115-2120.
24. Goldspink G, Scutt A, Loughna PT, Wells DJ, Jaenicke T, Gerlach GF. Gene expression in skeletal muscle in response to stretch and force generation. Am J Physiol 1992; 262: R356-R363.
25. Andersen JL, Mohr T, Biering-Sorensen F, Galbo H, Kjaer M. Myosin heavy chain isoform transformation in single fibres from m. vastus lateralis in spinal cord injured individuals: effects of long-term functional electrical stimulation (FES). Pflügers Arch 1996; 431: 513-518.
26. Booth FW, Gollnick PD. Effects of disuse on the structure and function of skeletal muscle. Med Sci Sports Exer 1983; 15: 415-420.
27. Larsson L, Ansved T. Effects of long-term physical training and detraining on enzyme histochemical and functional skeletal muscle characteristics in man. Muscle Nerve 1985; 8: 714-722.
28. Maltais F, Leblanc P, Simard C, et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 442-447.
29. Vescovo G, Serafini F, Facchin L, et al. Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis. Heart 1996; 76: 337-343.
30. Green HJ, Sutton JR, Cymerman A, Young PM, Houston CS. Operation Everest II: adaptations in human skeletal muscle. J Appl Physiol 1989; 66: 2454-2461.
31. Kamischke A, Kemper DE, Castel MA, et al. Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J 1998; 11: 41-15.
32. Wijkstra PJ, Ten Vergert EM, Van der Mark TW, et al. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax 1994; 49: 468-472.